However, this association was not observed in another experimental study testing the effects of bortezomib and another proteasome inhibitor on primary AML cells [207], whereas a study of AML cell lines described that bortezomib sensitized myelomonocytic AML cell lines to TRAIL-induced apoptosis [208]. The gene discussed is TNFSF10; the disease is acute myeloid leukemia.